[HTML][HTML] Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations

S Giralt, L Costa, J Schriber, J DiPersio… - Biology of Blood and …, 2014 - Elsevier
Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment
for malignancies such as multiple myeloma (MM) and lymphomas. Various changes in the …

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations

S Giralt, L Costa, J Schriber… - Biology of blood …, 2014 - pubmed.ncbi.nlm.nih.gov
Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment
for malignancies such as multiple myeloma (MM) and lymphomas. Various changes in the …

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: Consensus guidelines and recommendations

S Giralt, L Costa, J Schriber… - Biology of Blood …, 2014 - mdanderson.elsevierpure.com
Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment
for malignancies such as multiple myeloma (MM) and lymphomas. Various changes in the …

[PDF][PDF] Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

S Giralt, L Costa, J Schriber, J DiPersio… - Biol Blood Marrow …, 2014 - core.ac.uk
abstract Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established
treatment for malignancies such as multiple myeloma (MM) and lymphomas. Various …

[PDF][PDF] Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

S Giralt, L Costa, J Schriber, J DiPersio… - Biol Blood Marrow …, 2014 - researchgate.net
abstract Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established
treatment for malignancies such as multiple myeloma (MM) and lymphomas. Various …

[PDF][PDF] Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

J McCarty, P Shaughnessy, E Snyder… - Biol Blood Marrow …, 2013 - cyberleninka.org
abstract Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established
treatment for malignancies such as multiple myeloma (MM) and lymphomas. Various …

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: Consensus guidelines and recommendations

S Giralt, L Costa, J Schriber… - Biology of Blood …, 2014 - ohiostate.elsevierpure.com
Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment
for malignancies such as multiple myeloma (MM) and lymphomas. Various changes in the …

Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

S Giralt, L Costa, J Schriber, J DiPersio… - Biology of Blood and …, 2014 - infona.pl
Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment
for malignancies such as multiple myeloma (MM) and lymphomas. Various changes in the …

[HTML][HTML] Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

S Giralt, L Costa, J Schriber, J DiPersio… - Biology of Blood and …, 2014 - tctjournal.org
Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment
for malignancies such as multiple myeloma (MM) and lymphomas. Various changes in the …

[引用][C] Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

S Giralt, L Costa, J Schriber, J DiPersio… - Biology of Blood and …, 2014 - cir.nii.ac.jp
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes:
Consensus Guidelines and Recommendations | CiNii Research CiNii 国立情報学研究所 学術 …